FDA clears Medtronic Protecta ICDs, CRT-Ds

Justine Varieur Cadet | | Health Imaging | Diagnostic Imaging
The FDA has approved Medtronic’s Protecta portfolio of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds).

The new family of implantable defibrillators features SmartShock Technology, which includes six new Medtronic algorithms for arrhythmia recognition that deliver therapeutic shocks only when appropriate, according to the Minneapolis-based company. They include Wavelet + PR Logic, SVT discrimination in the VF zone and Confirmation; T-wave Discrimination and Lead Noise Discrimination; and Lead Integrity Alert, first released in 2008.

Shipments of the Protecta portfolio will begin immediately.

Justine Varieur Cadet

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.